On August 4^th, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Research Scientist in the Field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Senior Research Scientist

Country of Origin: China

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Texas

Approval Notice Date: August 4^th, 2017

Processing Time: 3 Months, 10 days (Premium Processing Requested)

Case Summary:

A senior research scientist from China hired North America Immigration Law Group (NAILG) to build and file an EB-1A (Alien of Extraordinary Ability) petition on his behalf. Exactly 3 months and 10 days later, he received notification of case approval.

Issuance of a Request for Evidence (RFE):

Although our client’s case was filed using Premium Processing, it took longer than expected to reach the EB1A finish line. This is because our client’s petition was issued an RFE. According to the USCIS, an RFE “is made when an application/petition is lacking required documentation/evidence (initial evidence) or the officer needs more documentation/evidence (additional evidence) to determine an applicant’s eligibility for the benefit sought.” As part of our services, we worked diligently to put together an RFE response package that proved the legitimacy of our client’s credentials. This subsequently led to petition approval.

What did the EB-1A petition contain?

To begin with, our team collated information on our client’s important research projects. We guided him in writing a research statement to split his work into three projects, with a specific focus attributed to each project. Taken together, we claimed that he has made substantial contributions to the field of immunology, particularly in the area of T-cell immunotherapy on human viruses and cancers, with a special focus on the ways in which T-cells control human specific viruses and various forms of cancer. We also emphasized that his studies have wide-ranging applications such as cancer research, drug discovery and development, clinical trial design, and virology.

We included a record of his academic achievements evident in his 14 published scientific articles, the 104 citations that they had accumulated at the time of filing, and the 80 peer reviews that he had conducted for a variety of scientific periodicals. To further strengthen his case, our client reached out to other experts in his field for recommendation letters, one of whom wrote: “He is certainly one of the most advanced individuals working in this area, and the continued improvement of the field is heavily dependent upon his continued research.”

Securing EB1A approval:

We were successful in proving that our client’s ongoing work in the field of immunology extends a major advantage to the American medical sector. We would like to congratulate him for obtaining EB1A petition approval and we wish him the best as he adjusts his status for permanent residence by filing an I-485 application with the help of our D.I.Y. Packet.